KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $115.1 million.

  • Evolent Health's Shares Outstanding (Diluted Average) rose 19.24% to $115.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.1 million, marking a year-over-year increase of 19.24%. This contributed to the annual value of $114.7 million for FY2024, which is 308.4% up from last year.
  • Per Evolent Health's latest filing, its Shares Outstanding (Diluted Average) stood at $115.1 million for Q3 2025, which was up 19.24% from $115.9 million recorded in Q2 2025.
  • Evolent Health's 5-year Shares Outstanding (Diluted Average) high stood at $115.9 million for Q2 2025, and its period low was $84.7 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $111.3 million (2023), whereas its average is $103.3 million.
  • As far as peak fluctuations go, Evolent Health's Shares Outstanding (Diluted Average) fell by 14.51% in 2021, and later surged by 2354.48% in 2023.
  • Over the past 5 years, Evolent Health's Shares Outstanding (Diluted Average) (Quarter) stood at $86.1 million in 2021, then grew by 8.87% to $93.7 million in 2022, then grew by 18.73% to $111.3 million in 2023, then rose by 3.08% to $114.7 million in 2024, then increased by 0.35% to $115.1 million in 2025.
  • Its last three reported values are $115.1 million in Q3 2025, $115.9 million for Q2 2025, and $115.3 million during Q1 2025.